Immunosuppression and probiotics: Are they effective and safe?

Beneficial Microbes

Volumn 6, Issue 6, 2015, Pages 823-828

  Stadlbauer, V ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Immunosuppression; Medical use; Probiotic

Indexed keywords

GALACTOSE OLIGOSACCHARIDE; PLACEBO; PROBIOTIC AGENT; SYNBIOTIC AGENT; IMMUNOSUPPRESSIVE AGENT;

ARTICLE; BACTERIAL TRANSLOCATION; BIFIDOBACTERIUM BREVE; BONE MARROW TRANSPLANTATION; CLOSTRIDIUM DIFFICILE INFECTION; CRITICALLY ILL PATIENT; DRUG EFFICACY; DRUG SAFETY; HEPATIC ENCEPHALOPATHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNOCOMPROMISED PATIENT; INFECTION PREVENTION; LACTOBACILLUS CASEI; LACTOBACILLUS PARACASEI; LACTOBACILLUS PLANTARUM; LACTOBACILLUS RHAMNOSUS; LEUCONOSTOC MESENTEROIDES; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MAJOR SURGERY; NONHUMAN; ORGAN TRANSPLANTATION; PEDIOCOCCUS PENTOSACEUS; POSTOPERATIVE INFECTION; SACCHAROMYCES BOULARDII; STEM CELL TRANSPLANTATION; URINARY TRACT INFECTION; ADVERSE DRUG REACTION;

DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; PROBIOTICS;

EID: 84949755726     PISSN: 18762883     EISSN: 18762891     Source Type: Journal    
DOI: 10.3920/BM2015.0065     Document Type: Article

References (36)

1. Bengmark, S., 2012. Pro and synbiotics to prevent sepsis in major surgery and severe emergencies. Nutrients 4: 91-111.
2. Besselink, M.G., Van Santvoort, H.C., Buskens, E., Boermeester, M.A., van Goor, H., Timmerman, H.M., Nieuwenhuijs, V.B., Bollen, T.L., Van Ramshorst, B., Witteman, B.J., Rosman, C., Ploeg, R.J., Brink, M.A., Schaapherder, A.F., Dejong, C.H., Wahab, P.J., Van Laarhoven, C.J., Van der Harst, E., Van Eijck, C.H., Cuesta, M.A., Akkermans, L.M., Gooszen, H.G. and Dutch Acute Pancreatitis Study, G., 2008. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. The Lancet 371: 651-659.
3. Chapman, C.M., Gibson, G.R. and Rowland, I., 2011. Health benefits of probiotics: are mixtures more effective than single strains? European Journal of Nutrition 50: 1-17.
4. Didari, T., Solki, S., Mozaffari, S., Nikfar, S. and Abdollahi, M., 2014. A systematic review of the safety of probiotics. Expert Opinion on Drug Safety 13: 227-239.
5. Eguchi, S., Takatsuki, M., Hidaka, M., Soyama, A., Ichikawa, T. and Kanematsu, T., 2011. Perioperative synbiotic treatment to prevent infectious complications in patients after elective living donor liver transplantation: a prospective randomized study. American Journal of Surgery 201: 498-502.
6. Food and Agriculture Organization of the United Nations/World Health Organization (FAO/WHO), 2001. Evaluation of health and nutritional properties of powder milk and live lactic acid bacteria. Available at: http://tinyurl.com/8bccc3r.
7. Floch, M.H., 2014. Recommendations for probiotic use in humans - a 2014 update. Pharmaceuticals 7: 999-1007.
8. Gerbitz, A., Schultz, M., Wilke, A., Linde, H.J., Scholmerich, J., Andreesen, R. and Holler, E., 2004. Probiotic effects on experimental graft-versus-host disease: let them eat yogurt. Blood 103: 4365-4367.
9. Gibson, G.R. and Roberfroid, M.B., 1995. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. Journal of Nutrition 125: 1401-1412.
10. Hell, M., Bernhofer, C., Stalzer, P., Kern, J.M. and Claassen, E., 2013. Probiotics in Clostridium difficile infection: reviewing the need for a multistrain probiotic. Beneficial Microbes 4: 39-51.
11. Hill, C., Guarner, F., Reid, G., Gibson, G.R., Merenstein, D.J., Pot, B., Morelli, L., Canani, R.B., Flint, H.J., Salminen, S., Calder, P.C. and Sanders, M.E., 2014. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nature Reviews Gastroenterology and Hepatology 11: 506-514.
12. Hummelen, R., Vos, A.P., Van't Land, B., Van Norren, K. and Reid, G., 2010. Altered host-microbe interaction in HIV: a target for intervention with pro and prebiotics. International Reviews of Immunology 29: 485-513.
13. Iqbal, M.Z., Qadir, M.I., Hussain, T., Janbaz, K.H., Khan, Y.H. and Ahmad, B., 2014. Review: probiotics and their beneficial effects against various diseases. Pakistan Journal of Pharmaceutical Sciences 27: 405-415.
14. Iwasa, M. and Takei, Y., in press. Pathophysiology and management of hepatic encephalopathy 2014 update: ammonia toxicity and hyponatremia. Hepatology Research. DOI: http://dx.doi.org/10.1111/hepr.12495.
15. Jacobi, C.A., Schulz, C. and Malfertheiner, P., 2011. Treating critically ill patients with probiotics: Bbeneficial or dangerous? Gut Pathogens 3: 2.
16. Leber, B., Spindelboeck, W. and Stadlbauer, V., 2012. Infectious complications of acute and chronic liver disease. Seminars in Respiratory and Critical Care Medicine 33: 80-95.
17. Lo, R.S., Austin, A.S. and Freeman, J.G., 2014. Is there a role for probiotics in liver disease? Scientific World Journal 2014: 874768.
18. Luong, M.L., Sareyyupoglu, B., Nguyen, M.H., Silveira, F.P., Shields, R.K., Potoski, B.A., Pasculle, W.A., Clancy, C.J. and Toyoda, Y., 2010. Lactobacillus probiotic use in cardiothoracic transplant recipients: a link to invasive Lactobacillus infection? Transplant Infectious Disease 12: 561-564.
19. Madsen, K., 2008. Probiotics in critically ill patients. Journal of Clinical Gastroenterology 42 Suppl. 3 Part 1: S116-S118.
20. Marchetti, G., Tincati, C. and Silvestri, G., 2013. Microbial translocation in the pathogenesis of HIV infection and AIDS. Clinical Microbiology Reviews 26: 2-18.
21. McGee, R.G., Bakens, A., Wiley, K., Riordan, S.M. and Webster, A.C., 2011. Probiotics for patients with hepatic encephalopathy. Cochrane Database of Systematic Reviews: CD008716.
22. Mehta, A., Rangarajan, S. and Borate, U., 2013. A cautionary tale for probiotic use in hematopoietic SCT patients - Lactobacillus acidophilus sepsis in a patient with mantle cell lymphoma undergoing hematopoietic SCT. Bone Marrow Transplantation 48: 461-462.
23. Pawlowska, J., Klewicka, E., Czubkowski, P., Motyl, I., Jankowska, I., Libudzisz, Z., Teisseyre, M., Gliwicz, D. and Cukrowska, B., 2007. Effect of Lactobacillus casei DN-114001 application on the activity of fecal enzymes in children after liver transplantation. Transplantation Proceedings 39: 3219-3221.
24. Rayes, N., Seehofer, D., Hansen, S., Boucsein, K., Muller, A.R., Serke, S., Bengmark, S. and Neuhaus, P., 2002a. Early enteral supply of Lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplant recipients. Transplantation 74: 123-127.
25. Rayes, N., Seehofer, D., Muller, A.R., Hansen, S., Bengmark, S. and Neuhaus, P., 2002b. [Influence of probiotics and fibre on the incidence of bacterial infections following major abdominal surgery - results of a prospective trial]. Zeitschrift fuer Gastroenterologie 40: 869-876 [in German].
26. Rayes, N., Seehofer, D., Theruvath, T., Schiller, R.A., Langrehr, J.M., Jonas, S., Bengmark, S. and Neuhaus, P., 2005. Supply of pre- and probiotics reduces bacterial infection rates after liver transplantation - a randomized, double-blind trial. American Journal of Transplantation 5: 125-130.
27. Ren, Z.G., Liu, H., Jiang, J.W., Jiang, L., Chen, H., Xie, H.Y., Zhou, L. and Zheng, S.S., 2011. Protective effect of probiotics on intestinal barrier function in malnourished rats after liver transplantation. Hepatobiliary and Pancreatic Diseases International 10: 489-496.
28. Rijkers, G.T., De Vos, W.M., Brummer, R.J., Morelli, L., Corthier, G. and Marteau, P., 2011. Health benefits and health claims of probiotics: bridging science and marketing. British Journal of Nutrition 106: 1291-1296.
29. Schrezenmeir, J. and De Vrese, M., 2001. Probiotics, prebiotics, and synbiotics - approaching a definition. American Journal of Clinical Nutrition 73: 361S-364S.
30. Stadlbauer, V., Mookerjee, R.P., Hodges, S., Wright, G.A., Davies, N.A. and Jalan, R., 2008. Effect of probiotic treatment on deranged neutrophil function and cytokine responses in patients with compensated alcoholic cirrhosis. Journal of Hepatology 48: 945-951.
31. Steyer, G.E. and Pfeifer, J., 2012. Multispezies Probiotika und Antibiotika. Review zur klinischen Evidenz bei der Prävention Antibiotika-Assoziierter Diarrhoe (AAD) und Clostridium difficile- Infektionen (CDI). OM & Ernährung 141: 38-41 [in German].
32. Tavil, B., Koksal, E., Yalcin, S.S. and Uckan, D., 2012. Pretransplant nutritional habits and clinical outcome in children undergoing hematopoietic stem cell transplant. Experimental and Clinical Transplantation 10: 55-61.
33. Van den Nieuwboer, M., Brummer, R.J., Guarner, F., Morelli, L., Cabana, M. and Claasen, E., 2015. The administration of probiotics and synbiotics in immune compromised adults: is it safe? Beneficial Microbes 6: 3-17.
34. Van der Meij, B.S., De Graaf, P., Wierdsma, N.J., Langius, J.A., Janssen, J.J., Van Leeuwen, P.A. and Visser, O.J., 2013. Nutritional support in patients with GVHD of the digestive tract: state of the art. Bone Marrow Transplantation 48: 474-482.
35. Xie, Y., Chen, H., Zhu, B., Qin, N., Chen, Y., Li, Z., Deng, M., Jiang, H., Xu, X., Yang, J., Ruan, B. and Li, L., 2014. Effect of intestinal microbiota alteration on hepatic damage in rats with acute rejection after liver transplantation. Microbial Ecology 68: 871-880.
36. Xie, Y.R., Liu, S.L., Liu, X., Luo, Z.B., Zhu, B., Li, Z.F., Li, L.J., He, Y., Jiang, L., Li, H. and Ruan, B., 2011. Intestinal microbiota and innate immunity-related gene alteration in cirrhotic rats with liver transplantation. Transplantation Proceedings 43: 3973-3979.